Futura Medical (LON:FUM) Stock Price Down 6.8% – What’s Next?

Futura Medical plc (LON:FUM) shares fell 6.8% during trading on Thursday . The company traded as low as GBX 0.37 and last traded at GBX 0.45. 3,423,739 shares changed hands during mid-day trading, a decline of 63% from the average session volume of 9,355,516 shares. The stock had previously closed at GBX 0.48.

Futura Medical Stock Down 10.9%

The company has a 50 day moving average of GBX 0.46 and a two-hundred day moving average of GBX 0.87. The firm has a market cap of £2.33 million, a P/E ratio of -0.14 and a beta of 0.02.

About Futura Medical

Futura Medical plc (AIM: FUM) is the developer of innovative sexual health products, including lead product Eroxon® and products WSD4000 and Eroxon® Intense. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.

Sexual health issues are prevalent in both men and women. ED impacts 1 in 5 men globally across all adult age brackets, with approximately half of all men over 40 experiencing ED and 25% of all new diagnoses being in men under 40.